Abstract
The complexity of cancer requires systems-level approaches to examine uncontrolled proliferation, with many analytical tools now providing massive information on distinct cellular processes. In contrast to the genetic anchors founded in cancer biology that underpin tumor suppressors and oncogenes as units of malignant function, we now see a shift of attention towards metabolism. This trend calls for the increased use of stable isotopic tracers to dissect effects in metabolic fluxes that arise from gene deregulation. When combined with analytical techniques such as mass spectrometry or nuclear magnetic resonance (NMR) and computational tools to interpret such datasets, isotopic tracers can allow for the determination of various metabolic events involved in tumorigenesis at a fine resolution. As such, the interplay between fluxes and signaling warrants a thorough investigation that will lead to targeted therapies rooted on metabolic targets. This chapter describes stable isotopic methods to determine fluxes and identify switches, illustrating how metabolic activity can be quantitatively interpreted to address fundamental questions in cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- 2HG:
-
R(2)-2-hydroxyglutarate
- AA:
-
Aminoacid
- ACL:
-
ATP citrate lyase
- AMP:
-
Adenosine 5′-monophosphate
- AMPK:
-
AMP-activated protein kinase
- ATP:
-
Adenosine 5′-triphosphate
- dN:
-
Deoxyribonucleoside
- DNNS:
-
De novo nucleoside synthesis
- dR:
-
deoxyribose (dR)
- EI:
-
Electron impact
- EMU:
-
Elementary metabolic unit
- ETC:
-
Electron transport chain
- FH:
-
Fumarate hydratase
- FSR:
-
Fractional synthesis rate
- GAP:
-
Glyceraldehyde 3-phosphate
- GC:
-
Gas Chromatography
- HK-II:
-
Hexokinase II
- IDH:
-
Isocitrate dehydrogenase
- ISA:
-
Isopotomer spectral analysis
- LC:
-
Liquid Chromatography
- LDH-A:
-
Lactate dehydrogenase A
- MFA:
-
Metabolic flux analysis
- MID:
-
Mass isotopomer distribution
- m/z:
-
Mass-to-charge ratio
- NEAA:
-
Non-essential amino acid
- NMFA:
-
Nonstationary metabolic flux analysis
- NTFDA:
-
Non-targeted tracer fate detection
- OXPHOS:
-
Oxidative phosphorylation
- PC:
-
Pyruvate carboxylase
- PDH:
-
Pyruvate dehydrogenase
- PEP:
-
Phosphoenolpyruvate
- PGAM1:
-
Phosphoglycerate mutase
- PK:
-
Pyruvate kinase
- PPP:
-
Pentose phosphate pathway
- TBDMS:
-
Tert-butyldimethylsilyl
- TCA:
-
Tricarboxylic acid
- TGF-β:
-
Transforming growth factor β
- TKT:
-
Transketolase
- TMS:
-
Trimethylsilyl
- VDAC:
-
Voltage-dependent anionic channel
References
Antoniewicz MR, Kelleher JK, Stephanopoulos G (2006) Determination of confidence intervals of metabolic fluxes estimated from stable isotope measurements. Metab Eng 8(4):324–337
Antoniewicz MR, Kelleher JK, Stephanopoulos G (2007) Accurate assessment of amino acid mass isotopomer distributions for metabolic flux analysis. Anal Chem 79(19):7554–7559
Antoniewicz MR, Kelleher JK, Stephanopoulos G (2007) Elementary metabolite units (EMU) – a novel framework for modeling isotopic distributions. Metab Eng 9(1):68–86
Baker M (2011) Metabolomics: from small molecules to big ideas. Nat Methods 8(2):117–121
Beckonert O, Keun HC, Ebbels TMD, Bundy J, Holmes E, Lindon JC, Nicholson JK (2007) Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc 2(11):2692–2703
Bennett BD, Yuan J, Kimball EH, Rabinowitz JD (2008) Absolute quantitation of intracellular metabolite concentrations by an isotope ratio-based approach. Nat Protoc 3(8):1299–1311
Bequette BJ, Sunny NE, El-Kadi SW, Owens SL (2006) Application of stable isotopes and mass isotopomer distribution analysis to the study of intermediary metabolism of nutrients. J Anim Sci 84(13 suppl):50–59
Beynon RJ, Pratt JM (2005) Metabolic labeling of proteins for proteomics. Mol Cell Proteomics (MCP) 4(7):857–872
Boros LG (2005) Metabolic targeted therapy of cancer: current tracer technologies and future drug design strategies in the old metabolic network. Metabolomics 1(1):11–15
Boros LG, Brackett DJ, Harrigan GG (2003) Metabolic biomarker and kinase drug target discovery in cancer using stable isotope-based dynamic metabolic profiling (SIDMAP). Curr Cancer Drug Targets 3(6):445–453
Boros LG, Torday JS, Lim S, Bassilian S, Cascante M, Lee WN (2000) Transforming growth factor beta2 promotes glucose carbon incorporation into nucleic acid ribose through the nonoxidative pentose cycle in lung epithelial carcinoma cells. Cancer Res 60(5):1183–1185
Busch R, Kim Y-K, Neese RA, Schade-Serin V, Collins M, Awada M, Gardner JL, Beysen C, Marino ME, Misell LM, Hellerstein MK (2006) Measurement of protein turnover rates by heavy water labeling of nonessential amino acids. Biochimica et Biophysica Acta (BBA) – General Subjects 1760(5):730–744
Busch R, Neese RA, Awada M, Hayes GM, Hellerstein MK (2007) Measurement of cell proliferation by heavy water labeling. Nat Protoc 2(12):3045–3057
Cairns RA, Harris IS, Mak TW (2011) Regulation of cancer cell metabolism. Nat Rev Cancer 11:85–95. doi:10.1038/nrc2981
Cascante M, Boros LG, Comin-Anduix B, de Atauri P, Centelles JJ, Lee PWN (2002) Metabolic control analysis in drug discovery and disease. Nat Biotechnol 20(3):243–249
Chatham JC, Bouchard B, Des Rosiers C (2003) A comparison between NMR and GCMS 13 C-isotopomer analysis in cardiac metabolism. Mol Cell Biochem 249(1–2):105–112
Chatterjee A, Mambo E, Sidransky D (2006) Mitochondrial DNA mutations in human cancer. Oncogene 25(34):4663–4674
Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A, Gerszten RE, Wei R, Fleming MD, Schreiber SL, Cantley LC (2008) The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452(7184):230–233
Christofk HR, Vander Heiden MG, Wu N, Asara JM, Cantley LC (2008) Pyruvate kinase M2 is a phosphotyrosine-binding protein. Nature 452(7184):181–186
Czernin J, Phelps ME (2002) Positron emission tomography scanning: current and future applications. Annu Rev Med 53(1):89–112
Dang CV (2009) PKM2 Tyrosine phosphorylation and glutamine metabolism signal a different view of the Warburg effect. Sci Signal 2(97):pe75
Dang CV (2010) Glutaminolysis: supplying carbon or nitrogen, or both for cancer cells? Cell Cycle 9(19):3884–3886
Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, Fantin VR, Jang HG, Jin S, Keenan MC, Marks KM, Prins RM, Ward PS, Yen KE, Liau LM, Rabinowitz JD, Cantley LC, Thompson CB, Vander Heiden MG, Su SM (2009) Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462(7274):739–744
David CJ, Chen M, Assanah M, Canoll P, Manley JL (2010) HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature 463(7279):364–368
DeBerardinis RJ, Cheng T (2010) Q’s next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene 29(3):313–324
DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB (2008) The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 7(1):11–20
DeBerardinis RJ, Mancuso A, Daikhin E, Nissim I, Yudkoff M, Wehrli S, Thompson CB (2007) Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci U S A 104(49):19345–19350
Denkert C, Budczies J, Weichert W, Wohlgemuth G, Scholz M, Kind T, Niesporek S, Noske A, Buckendahl A, Dietel M, Fiehn O (2008) Metabolite profiling of human colon carcinoma – deregulation of TCA cycle and amino acid turnover. Mol Cancer 7:72
Deshpande R, Yang TH, Heinzle E (2009) Towards a metabolic and isotopic steady state in CHO batch cultures for reliable isotope-based metabolic profiling. Biotechnol J 4(2):247–263
Diraison F, Pachiaudi C, Beylot M (1996) In vivo measurement of plasma cholesterol and fatty acid synthesis with deuterated water: Determination of the average number of deuterium atoms incorporated. Metabolism 45(7):817–821
Dunn WB, Bailey NJC, Johnson HE (2005) Measuring the metabolome: current analytical technologies. Analyst 130(5):606–625
Elstrom RL, Bauer DE, Buzzai M, Karnauskas R, Harris MH, Plas DR, Zhuang H, Cinalli RM, Alavi A, Rudin CM, Thompson CB (2004) Akt stimulates aerobic glycolysis in cancer cells. Cancer Res 64(11):3892–3899. doi:10.1158/0008-5472.CAN-03-2904
Fan MZ, Chiba LI, Matzat PD, Yang X, Yin YL, Mine Y, Stein HH (2006) Measuring synthesis rates of nitrogen-containing polymers by using stable isotope tracers. J Anim Sci 84(13 suppl):E79–E93
Fell DA (2004) Enzymes, metabolites and fluxes. J Exp Bot 56(410):267–272
Fernandez CA, Rosiers CD, Previs SF, David F, Brunengraber H (1996) Correction of 13 C mass isotopomer distributions for natural stable isotope abundance. J Mass Spectrom 31(3):255–262
Fiehn O, Kopka J, Dormann P, Altmann T, Trethewey RN, Willmitzer L (2000) Metabolite profiling for plant functional genomics. Nat Biotechnol 18(11):1157–1161
Fischer E, Zamboni N, Sauer U (2004) High-throughput metabolic flux analysis based on gas chromatography-mass spectrometry derived 13 C constraints. Anal Biochem 325(2):308–316
Forbes NS, Meadows AL, Clark DS, Blanch HW (2006) Estradiol stimulates the biosynthetic pathways of breast cancer cells: detection by metabolic flux analysis. Metab Eng 8(6):639–652
Funes JM, Quintero M, Henderson S, Martinez D, Qureshi U, Westwood C, Clements MO, Bourboulia D, Pedley RB, Moncada S, Boshoff C (2007) Transformation of human mesenchymal stem cells increases their dependency on oxidative phosphorylation for energy production. Proc Natl Acad Sci USA 104(15):6223–6228
Gatenby RA, Gillies RJ (2004) Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4(11):891–899
Gogvadze V, Orrenius S, Zhivotovsky B (2008) Mitochondria in cancer cells: what is so special about them? Trends Cell Biol 18(4):165–173
Griffin JL, Shockcor JP (2004) Metabolic profiles of cancer cells. Nat Rev Cancer 4(7):551–561
Gruetter R, Adriany G, Choi I-Y, Henry P-G, Lei H, Öz G (2003) Localized in vivo13C NMR spectroscopy of the brain. NMR Biomed 16(6–7):313–338
Halket JM, Waterman D, Przyborowska AM, Patel RKP, Fraser PD, Bramley PM (2005) Chemical derivatization and mass spectral libraries in metabolic profiling by GC/MS and LC/MS/MS. J Exp Bot 56(410):219–243
Hao W, Chang C-PB, Tsao C-C, Xu J (2010) Oligomycin-induced bioenergetic adaptation in cancer cells with heterogeneous bioenergetic organization. J Biol Chem 285(17):12647–12654
Hatzivassiliou G, Zhao F, Bauer DE, Andreadis C, Shaw AN, Dhanak D, Hingorani SR, Tuveson DA, Thompson CB (2005) ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell 8(4):311–321
Hellerstein M (2000) Methods for measuring polymerisation biosynthesis: three general solutions to the problem of the “true precursor”. Diabetes Nutr Metab 13(1):46–60
Hellerstein MK (2004) New stable isotope-mass spectrometric techniques for measuring fluxes through intact metabolic pathways in mammalian systems: introduction of moving pictures into functional genomics and biochemical phenotyping. Metab Eng 6(1):85–100
Hellerstein MK, Neese RA (1992) Mass isotopomer distribution analysis: a technique for measuring biosynthesis and turnover of polymers. Am J Physiol 263(5 Pt 1):E988–E1001
Hellerstein MK, Neese RA (1999) Mass isotopomer distribution analysis at eight years: theoretical, analytic, and experimental considerations. Am J Physiol 276(6 Pt 1):E1146–E1170
Hiller K, Metallo CM, Kelleher JK, Stephanopoulos G (2010) Nontargeted elucidation of metabolic pathways using stable-isotope tracers and mass spectrometry. Anal Chem 82(15):6621–6628
Hiller K, Metallo C, Stephanopoulos G (2011) Elucidation of cellular metabolism via metabolomics and stable-isotope assisted metabolomics. Curr Pharm Biotechnol 12(7):1075–1086
Jones JG, Garcia P, Barosa C, Delgado TC, Diogo L (2009) Hepatic anaplerotic outflow fluxes are redirected from gluconeogenesis to lactate synthesis in patients with Type 1a glycogen storage disease. Metab Eng 11(3):155–162
Jones RG, Thompson CB (2009) Tumor suppressors and cell metabolism: a recipe for cancer growth. Genes Dev 23(5):537–548
Kaadige MR, Looper RE, Kamalanaadhan S, Ayer DE (2009) Glutamine-dependent anapleurosis dictates glucose uptake and cell growth by regulating MondoA transcriptional activity. Proc Natl Acad Sci 106(35):14878–14883
Kacser H, Burns JA (1973) The control of flux. Symp Soc Exp Biol 27:65–104
Kaelin WG, Thompson CB (2010) Q&A: cancer: clues from cell metabolism. Nature 465(7298):562–564
Kelleher JK (2001) Flux estimation using isotopic tracers: common ground for metabolic physiology and metabolic engineering. Metab Eng 3(2):100–110
Kelleher JK, Masterson TM (1992) Model equations for condensation biosynthesis using stable isotopes and radioisotopes. Am J Physiol 262(1 Pt 1):E118–E125
Kharroubi AT, Masterson TM, Aldaghlas TA, Kennedy KA, Kelleher JK (1992) Isotopomer spectral analysis of triglyceride fatty acid synthesis in 3 T3-L1 cells. Am J Physiol 263(4 Pt 1):E667–E675
Kim J-w, Dang CV (2006) Cancer’s molecular sweet tooth and the Warburg effect. Cancer Res 66(18):8927–8930
Koshland DE (1998) The era of pathway quantification. Science 280(5365):852–853
Kresge N, Simoni RD, Hill RL (2005) Otto Fritz Meyerhof and the elucidation of the glycolytic pathway. J Biol Chem 280(4):e3
Lane AN, Fan TWM, Higashi RM (2008) Stable isotope-assisted metabolomics in cancer research. IUBMB Life 60(2):124–129
Langbein S, Zerilli M, Az H, Staiger W, Rensch-Boschert K, Lukan N, Popa J, Ternullo MP, Steidler A, Weiss C, Grobholz R, Willeke F, Alken P, Stassi G, Schubert P, Coy JF (2006) Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted. Br J Cancer 94(4):578–585
Levine AJ, Puzio-Kuter AM (2010) The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science 330(6009):1340–1344
Lu D, Mulder H, Zhao P, Burgess SC, Jensen MV, Kamzolova S, Newgard CB, Sherry AD (2002) 13 C NMR isotopomer analysis reveals a connection between pyruvate cycling and glucose-stimulated insulin secretion (GSIS). Proc Natl Acad Sci U S A 99(5):2708–2713
Luo W, Hu H, Chang R, Zhong J, Knabel M, O’Meally R, Cole RN, Pandey A, Semenza GL (2011) Cell 145(5):732–744
Macallan DC, Fullerton CA, Neese RA, Haddock K, Park SS, Hellerstein MK (1998) Measurement of cell proliferation by labeling of DNA with stable isotope-labeled glucose: studies in vitro, in animals, and in humans. Proc Natl Acad Sci USA 95(2):708–713
Maier K, Hofmann U, Bauer A, Niebel A, Vacun G, Reuss M, Mauch K (2009) Quantification of statin effects on hepatic cholesterol synthesis by transient 13 C-flux analysis. Metab Eng 11(4–5):292–309
Maier K, Hofmann U, Reuss M, Mauch K (2008) Identification of metabolic fluxes in hepatic cells from transient 13 C-labeling experiments: part II. Flux estimation. Biotechnol Bioeng 100(2):355–370
Malloy CR, Sherry AD, Jeffrey FM (1988) Evaluation of carbon flux and substrate selection through alternate pathways involving the citric acid cycle of the heart by 13 C NMR spectroscopy. J Biol Chem 263(15):6964–6971
Mancuso A, Sharfstein ST, Tucker SN, Clark DS, Blanch HW (1994) Examination of primary metabolic pathways in a murine hybridoma with carbon-13 nuclear magnetic resonance spectroscopy. Biotechnol Bioeng 44(5):563–585
Martini WZ, Chinkes DL, Wolfe RR (2004) Quantification of DNA synthesis from different pathways in cultured human fibroblasts and myocytes. Metabolism 53(1):128–133
Mathupala SP, Ko YH, Pedersen PL (2006) Hexokinase II: cancer’s double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria. Oncogene 25(34):4777–4786
Mazurek S, Boschek CB, Hugo F, Eigenbrodt E (2005) Pyruvate kinase type M2 and its role in tumor growth and spreading. Semin Cancer Biol 15(4):300–308. doi:10.1016/j.semcancer.2005.04.009
McKnight SL (2010) On getting there from here. Science (New York, NY) 330(6009):1338–1339
Meadows AL, Kong B, Berdichevsky M, Roy S, Rosiva R, Blanch HW, Clark DS (2008) Metabolic and morphological differences between rapidly proliferating cancerous and normal breast epithelial cells. Biotechnol Prog 24(2):334–341
Metallo CM, Vander Heiden MG (2010) Metabolism strikes back: metabolic flux regulates cell signaling. Genes Dev 24(24):2717–2722
Metallo CM, Walther JL, Stephanopoulos G (2009) Evaluation of 13 C isotopic tracers for metabolic flux analysis in mammalian cells. J Biotechnol 144(3):167–174
Miccheli A, Tomassini A, Puccetti C, Valerio M, Peluso G, Tuccillo F, Calvani M, Manetti C, Conti F (2006) Metabolic profiling by 13 C-NMR spectroscopy: [1,2-13 C2]glucose reveals a heterogeneous metabolism in human leukemia T cells. Biochimie 88(5):437–448
Munger J, Bennett BD, Parikh A, Feng X-J, McArdle J, Rabitz HA, Shenk T, Rabinowitz JD (2008) Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy. Nat Biotechnol 26(10):1179–1186
Neermann J, Wagner R (1996) Comparative analysis of glucose and glutamine metabolism in transformed mammalian cell lines, insect and primary liver cells. J Cell Physiol 166(1):152–169
Neese RA, Siler SQ, Cesar D, Antelo F, Lee D, Misell L, Patel K, Tehrani S, Shah P, Hellerstein MK (2001) Advances in the stable isotope-mass spectrometric measurement of DNA synthesis and cell proliferation. Anal Biochem 298(2):189–195
Newsholme EA, Crabtree B, Ardawi MS (1985) The role of high rates of glycolysis and glutamine utilization in rapidly dividing cells. Biosci Rep 5(5):393–400
Nicholson JK, Connelly J, Lindon JC, Holmes E (2002) Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov 1(2):153–161
Nicklin P, Bergman P, Zhang B, Triantafellow E, Wang H, Nyfeler B, Yang H, Hild M, Kung C, Wilson C, Myer VE, MacKeigan JP, Porter JA, Wang YK, Cantley LC, Finan PM, Murphy LO (2009) Bidirectional transport of amino acids regulates mTOR and autophagy. Cell 136(3):521–534
Nielsen J (2003) It is all about metabolic fluxes. J Bacteriol 185:7031–7035
Niklas J, Schneider K, Heinzle E (2010) Metabolic flux analysis in eukaryotes. Curr Opin Biotechnol 21(1):63–69
Noack S, Nöh K, Moch M, Oldiges M, Wiechert W (2011) Stationary versus non-stationary 13 C-MFA: a comparison using a consistent dataset. J Biotechnol 154(2–3):179–190
Noguchi Y, Young JD, Aleman JO, Hansen ME, Kelleher JK, Stephanopoulos G (2009) Effect of anaplerotic fluxes and amino acid availability on hepatic lipoapoptosis. J Biol Chem 284(48):33425–33436. doi:10.1074/jbc.M109.049478
Ohie T, Fu X-w, Iga M, Kimura M, Yamaguchi S (2000) Gas chromatography-mass spectrometry with tert.-butyldimethylsilyl derivatization: use of the simplified sample preparations and the automated data system to screen for organic acidemias. J Chromatogr B Biomed Sci Appl 746(1):63–73
Ortega ÁD, Sánchez-Aragó M, Giner-Sánchez D, Sánchez-Cenizo L, Willers I, Cuezva JM (2009) Glucose avidity of carcinomas. Cancer Lett 276(2):125–135
Patterson BW (1997) Use of stable isotopically labeled tracers for studies of metabolic kinetics: an overview. Metabolism 46(3):322–329
Pedersen P (2007) Warburg, me and hexokinase 2: multiple discoveries of key molecular events underlying one of cancers’ most common phenotypes, the “Warburg effect”, i.e., elevated glycolysis in the presence of oxygen. J Bioenerg Biomembr 39(3):211–222
Perez JF, Reeds PJ (1998) A new stable isotope method enables the simultaneous measurement of nucleic acid and protein synthesis in vivo in mice. J Nutr 128(9):1562–1569
Pfeiffer T, Schuster S, Bonhoeffer S (2001) Cooperation and competition in the evolution of ATP-producing pathways. Science 292(5516):504–507
Portais J-C, Schuster R, Merle M, Canioni P (1993) Metabolic flux determination in C6 glioma cells using carbon-13 distribution upon [1-13 C]glucose incubation. Eur J Biochem 217(1):457–468
Poste G (2011) Bring on the biomarkers. Nature 469(7329):156–157
Quek L-E, Wittmann C, Nielsen L, Kromer J (2009) OpenFLUX: efficient modelling software for 13 C-based metabolic flux analysis. Microb Cell Fact 8(1):25
Robey RB, Hay N (2009) Is Akt the “Warburg kinase”?–Akt-energy metabolism interactions and oncogenesis. Semin Cancer Biol 19(1):25–31
Rodríguez-Enríquez S, Marín-Hernández A, Gallardo-Pérez JC, Carreño-Fuentes L, Moreno-Sánchez R (2009) Targeting of cancer energy metabolism. Mol Nutr Food Res 53(1):29–48
Salway JG (2004) Metabolism at a glance, 3rd edn. Blackwell, Malden
Sauer U (2006) Metabolic networks in motion: 13 C-based flux analysis. Mol Syst Biol 2:62. doi:10.1038/msb4100109
Sauer LA, Dauchy RT, Nagel WO, Morris HP (1980) Mitochondrial malic enzymes. Mitochondrial NAD(P) + -dependent malic enzyme activity and malate-dependent pyruvate formation are progression-linked in Morris hepatomas. J Biol Chem 255(9):3844–3848
Sazanov LA, Jackson JB (1994) Proton-translocating transhydrogenase and NAD- and NADP-linked isocitrate dehydrogenases operate in a substrate cycle which contributes to fine regulation of the tricarboxylic acid cycle activity in mitochondria. FEBS Lett 344(2–3):109–116
Schmidt K, Carlsen M, Nielsen J, Villadsen J (1997) Modeling isotopomer distributions in biochemical networks using isotopomer mapping matrices. Biotechnol Bioeng 55(6):831–840
Shackelford DB, Shaw RJ (2009) The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat Rev Cancer 9(8):563–575
Shaw RJ, Cantley LC (2006) Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 441(7092):424–430
Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM (2009) Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457(7231):910–914
Stephanopoulos G, Aristidou AA, Nielsen J (1998) Metabolic engineering: principles and methodologies. Academic, San Diego
Stephanopoulos G, Vallino JJ (1991) Network rigidity and metabolic engineering in metabolite overproduction. Science 252(5013):1675–1681
Stratton MR, Campbell PJ, Futreal PA (2009) The cancer genome. Nature 458(7239):719–724. doi:10.1038/nature07943
Szyperski T (1995) Biosynthetically directed fractional 13 C-labeling of proteinogenic amino acids. An efficient analytical tool to investigate intermediary metabolism. Eur J Biochem/FEBS 232(2):433–448
Tennant DA, Duran RV, Gottlieb E (2010) Targeting metabolic transformation for cancer therapy. Nat Rev Cancer 10(4):267–277
Tolstonog GV, Deppert W (2010) Metabolic sensing by p53: keeping the balance between life and death. Proc Natl Acad Sci 107(30):13193–13194
Tong X, Zhao F, Mancuso A, Gruber JJ, Thompson CB (2009) The glucose-responsive transcription factor ChREBP contributes to glucose-dependent anabolic synthesis and cell proliferation. Proc Natl Acad Sci USA 106(51):21660–21665. doi:10.1073/pnas.0911316106
Tong X, Zhao F, Thompson CB (2009) The molecular determinants of de novo nucleotide biosynthesis in cancer cells. Curr Opin Genet Dev 19(1):32–37. doi:10.1016/j.gde.2009.01.002
Van Winden W, Verheijen P, Heijnen S (2001) Possible pitfalls of flux calculations based on 13 C-labeling. Metab Eng 3(2):151–162
Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324(5930):1029–1033
Vander Heiden MG, Locasale JW, Swanson KD, Sharfi H, Heffron GJ, Amador-Noguez D, Christofk HR, Wagner G, Rabinowitz JD, Asara JM, Cantley LC (2010) Evidence for an alternative glycolytic pathway in rapidly proliferating cells. Science 329(5998):1492–1499
Vizan P, Boros LG, Figueras A, Capella G, Mangues R, Bassilian S, Lim S, Lee W-NP, Cascante M (2005) K-ras codon-specific mutations produce distinctive metabolic phenotypes in human fibroblasts. Cancer Res 65(13):5512–5515
Vogelstein B, Kinzler KW (2004) Cancer genes and the pathways they control. Nat Med 10(8):789–799
Wamelink MMC, Struys EA, Huck JHJ, Roos B, van der Knaap MS, Jakobs C, Verhoeven NM (2005) Quantification of sugar phosphate intermediates of the pentose phosphate pathway by LC-MS/MS: application to two new inherited defects of metabolism. J Chromatogr B 823(1):18–25
Warburg O (1956) On respiratory impairment in cancer cells. Science 124(3215):269–270
Warburg O (1956) On the origin of cancer cells. Science 123(3191):309–314
Ward PS, Patel J, Wise DR, Abdel-Wahab O, Bennett BD, Coller HA, Cross JR, Fantin VR, Hedvat CV, Perl AE, Rabinowitz JD, Carroll M, Su SM, Sharp KA, Levine RL, Thompson CB (2010) The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting [alpha]-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 17(3):225–234
Watt PW, Lindsay Y, Scrimgeour CM, Chien PA, Gibson JN, Taylor DJ, Rennie MJ (1991) Isolation of aminoacyl-tRNA and its labeling with stable-isotope tracers: use in studies of human tissue protein synthesis. Proc Natl Acad Sci USA 88(13):5892–5896
Weinberg F, Hamanaka R, Wheaton WW, Weinberg S, Joseph J, Lopez M, Kalyanaraman B, Mutlu GM, Budinger GRS, Chandel NS (2010) Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc Natl Acad Sci USA 107(19):8788–8793
Wellen KE, Hatzivassiliou G, Sachdeva UM, Bui TV, Cross JR, Thompson CB (2009) ATP-citrate lyase links cellular metabolism to histone acetylation. Science 324(5930):1076–1080
Wiechert W (2001) 13 C metabolic flux analysis. Metab Eng 3(3):195–206
Wiechert W, Nöh K (2005) From stationary to instationary metabolic flux analysis. Adv Biochem Eng Biotechnol 92:145–172
Wise DR, DeBerardinis RJ, Mancuso A, Sayed N, Zhang X-Y, Pfeiffer HK, Nissim I, Daikhin E, Yudkoff M, McMahon SB, Thompson CB (2008) Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc Natl Acad Sci USA 105(48):18782–18787
Wolfe RR, Chinkles DL (2004) Measurement of the synthesis of specific products. In: Isotope tracers in metabolic research: principles and practice of kinetic analysis, 2nd edn. Wiley, Hoboken, pp 325–360
Wu M, Neilson A, Swift AL, Moran R, Tamagnine J, Parslow D, Armistead S, Lemire K, Orrell J, Teich J, Chomicz S, Ferrick DA (2007) Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells. Am J Physiol Cell Physiol 292(1):C125–C136
Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ, Friedman H, Friedman A, Reardon D, Herndon J, Kinzler KW, Velculescu VE, Vogelstein B, Bigner DD (2009) IDH1 And IDH2 mutations in gliomas. N Engl J Med 360(8):765–773
Yang TH, Frick O, Heinzle E (2008) Hybrid optimization for 13 C metabolic flux analysis using systems parametrized by compactification. BMC Syst Biol 2(1):29
Yen KE, Bittinger MA, Su SM, Fantin VR (2010) Cancer-associated IDH mutations: biomarker and therapeutic opportunities. Oncogene 29(49):6409–6417
Yeung SJ, Pan J, Lee MH (2008) Roles of p53, Myc and HIF-1 in regulating glycolysis — the seventh hallmark of cancer. Cell Mol Life Sci 65(24):3981–3999
Yoo H, Stephanopoulos G, Kelleher JK (2004) Quantifying carbon sources for de novo lipogenesis in wild-type and IRS-1 knockout brown adipocytes. J Lipid Res 45(7):1324–1332
Yoo H, Antoniewicz MR, Stephanopoulos G, Kelleher JK (2008) J Biol Chem 283(30):20621–20627
Young JD, Walther JL, Antoniewicz MR, Yoo H, Stephanopoulos G (2008) An elementary metabolite unit (EMU) based method of isotopically nonstationary flux analysis. Biotechnol Bioeng 99(3):686–699. doi:10.1002/bit.21632
Yun J, Rago C, Cheong I, Pagliarini R, Angenendt P, Rajagopalan H, Schmidt K, Willson JKV, Markowitz S, Zhou S, Diaz LA, Velculescu VE, Lengauer C, Kinzler KW, Vogelstein B, Papadopoulos N (2009) Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells. Science 325(5947):1555–1559
Zamboni N, Fendt S-M, Ruhl M, Sauer U (2009)13C-based metabolic flux analysis. Nat Protoc 4(6):878–892
Zhang X-j, Chinkes DL, Wu Z, Martini WZ, Wolfe RR (2004) Fractional synthesis rates of DNA and protein in rabbit skin are not correlated. J Nutr 134(9):2401–2406
Zupke C, Sinskey AJ, Stephanopoulos G (1995) Intracellular flux analysis applied to the effect of dissolved oxygen on hybridomas. Appl Microbiol Biotechnol 44(1–2):27–36
Zupke C, Stephanopoulos G (1994) Modeling of isotope distributions and intracellular fluxes in metabolic networks using atom mapping matrixes. Biotechnol Prog 10(5):489–498
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Gameiro, P.A., Metallo, C.M., Stephanopoulos, G. (2012). Systems-Level Analysis of Cancer Metabolism. In: Wittmann, C., Lee, S. (eds) Systems Metabolic Engineering. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-4534-6_11
Download citation
DOI: https://doi.org/10.1007/978-94-007-4534-6_11
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-4533-9
Online ISBN: 978-94-007-4534-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)